AUSTIN, TX / ACCESS Newswire / February 5, 2025 / Volcon, Inc. (NASDAQ:VLCN) (the "Company"), the first all-electric, off-road ...

Volcon (VLCN) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the company expected to be ...

Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), a company engaged in developing drug delivery systems for pain management, announced the pricing of its public offering at $0.20 per share of ...

The Capital Market Authority (CMA) approved Saudi Economic and Development Securities Co.’s (SEDCO) request for the public ...

CERo Therapeutics (CERO) announced the pricing of its “reasonable best efforts” public offering with participation from a ...

today announced the pricing of a best-efforts public offering of 762,500 common shares at a public offering price of $4.00 per share. Total gross proceeds from the offering, before deducting ...

In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.

Akero Therapeutics announced a public offering of over 5.3 million shares at $48 each, aiming for $350 million in proceeds. Akero Therapeutics, Inc. has announced a public offering of 5,333,420 ...

Investing.com -- Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company ...